New book by Larry Connors Click here Improve your trading - See how
New orders in the quarter totaled $339 million, down 4 percent compared to the prior-year period. Sales in the quarter totaled $323 million, 12 percent lower than the prior-year period.
Third quarter 2009 operating income, adjusted for restructuring related charges of $2.8 million, was $49 million and resulted in adjusted operating margin of 15.2 percent, down 290 basis points from prior year (excluding prior year restructuring related charges of $5.3 million and goodwill impairment charges of $30 million). On an as-reported basis, third quarter operating income of $47 million was 51 percent higher than the prior-year period.
Excluding the impact of restructuring related charges, third quarter 2009 adjusted diluted earnings per share was 39 cents, a decrease of 13 cents, or 25 percent, from the third quarter of the previous year (excluding prior year unfavorable impact of restructuring related charges and goodwill impairment charges). On an as-reported basis, diluted earnings per share of 37 cents increased 13 cents, or 54 percent, from the third quarter of the previous year.
Third Quarter 2009 Results
-- Orders declined 4 percent compared to the prior year (+7 percent acquisitions, -9 percent organic and -2 percent foreign currency translation).
-- Sales declined 12 percent compared to the prior year (+7 percent acquisitions, -17 percent organic and -2 percent foreign currency translation).
-- Reported net income was $30 million, or 50 percent higher than the prior year. Adjusted net income of $32 million was $12 million, or 27 percent, lower than the prior year (excluding prior year restructuring and goodwill impairment charges).
-- Diluted EPS of 37 cents was 13 cents, or 54 percent, higher than the prior year. Adjusted diluted EPS of 39 cents was 13 cents, or 25 percent, lower than the prior year (excluding prior year impact of restructuring and goodwill impairment charges).
-- EBITDA of $62 million was 19 percent of sales and covered interest expense by more than 15 times.
-- Free cash flow of $78 million, 15 percent higher than prior year, was an all-time high.
"We achieved solid profit performance and excellent cash flow in the third quarter. Our operating model and flexible cost structure once again illustrates that we can limit the unfavorable margin impact in a down sales environment while continuing to focus on growing market share, demonstrating outstanding responsiveness to changing order patterns and new business opportunities. We continue to generate very strong cash flow, converting 175 percent of net income to free cash thus far in our year-to-date results.
As we look to the fourth quarter, we expect that energy, water, and select health and science end markets will reflect sequential improvement; while the industrial process, retail paint dispensing, and fire suppression end markets will be slightly down sequentially.
Based on current conditions, our projected fourth quarter EPS is in the range of 35 to 37 cents on a fully diluted basis. For the full year, we expect organic revenue to decline approximately 15 percent resulting in adjusted diluted EPS of $1.44 to $1.46."
Lawrence D. Kingsley Chairman and Chief Executive Officer
Business Highlights (excluding restructuring related charges)
Fluid & Metering Technologies
-- Sales in the third quarter of $157 million reflected an 8 percent decline compared to the third quarter of 2008 (+12 percent acquisitions, -19 percent organic and -1 percent foreign currency translation).
-- Operating margin of 16.8 percent represented a 390 basis point decline compared with the third quarter of 2008. Excluding the impact of acquisitions, operating margin was 18.4 percent, a 230 basis point decline compared with the prior-year period due to lower sales.
Health & Science Technologies
-- Sales in the third quarter of $76 million reflected an 8 percent decline compared to the third quarter of 2008 (+6 percent acquisitions, -13 percent organic and -1 percent foreign currency translation). The organic decline was primarily due to continued market softness in the non-core HST businesses.
-- Operating margin of 20.1 percent reflected a 120 basis point decline compared with the third quarter of 2008. Excluding the impact of the Semrock acquisition, operating margin was 19.7 percent, a 160 basis point decline compared with the prior-year period due to lower sales.
Dispensing Equipment
-- Sales of $26 million in the third quarter reflected a 19 percent decline compared with the third quarter of 2008 (-15 percent organic and -4 percent foreign currency translation), as a result of continued deterioration in capital spending for both the North American and European markets.
-- Operating margin of 1.2 percent reflected a 180 basis point decline compared with the third quarter of 2008 due to lower volumes in North America and Europe (excluding prior year goodwill impairment charge).
Fire & Safety/Diversified Products
-- Sales in the third quarter of $66 million reflected a 19 percent decline compared with the third quarter of 2008 (-16 percent organic and -3 percent foreign currency translation).
-- Operating margin of 24.4 percent represented a 90 basis point decline compared with the third quarter of 2008 on lower volumes and unfavorable product mix within the segment.
For the third quarter of 2009, Fluid & Metering Technologies contributed 48 percent of sales and 46 percent of operating income; Health & Science Technologies accounted for 24 percent of sales and 25 percent of operating income; Dispensing Equipment accounted for 8 percent of sales and 1 percent of operating income; and Fire & Safety/Diversified Products represented 20 percent of sales and 28 percent of operating income.
Conference Call to be Broadcast over the Internet
IDEX will broadcast its third quarter earnings conference call over the Internet on Tuesday, October 20, 2009 at 9:30 a.m. CT. Chairman and Chief Executive Officer Larry Kingsley and Vice President and Chief Financial Officer Dominic Romeo will discuss the company's recent financial performance and respond to questions from the financial analyst community. IDEX invites interested investors to listen to the call and view the accompanying slide presentation, which will be carried live on its website at www.idexcorp.com. Those who wish to participate should log on several minutes before the discussion begins. After clicking on the presentation icon, investors should follow the instructions to ensure their systems are set up to hear the event and view the presentation slides, or download the correct applications at no charge. Investors will also be able to hear a replay of the call by dialing 888.203.1112 (or 719.457.0820 for international participants) using the ID # 2354138.
A Note on EBITDA and Free Cash Flow
EBITDA means earnings before interest, income taxes, depreciation and amortization, while free cash flow means cash flow from operating activities less capital expenditures plus the excess tax benefit from stock-based compensation. Management uses these non-GAAP financial measures as internal operating metrics and for enterprise valuation purposes. Management believes these measures are useful as analytical indicators of leverage capacity and debt servicing ability, and uses them to measure financial performance as well as for planning purposes. However, they should not be considered as alternatives to net income, cash flow from operating activities or any other items calculated in accordance with U.S. GAAP, or as an indicator of operating performance. The definitions of EBITDA and free cash flow used here may differ from those used by other companies.
EBITDA and Free Cash Flow bridge For the Quarter Ended
September 30, June 30,
2009 2008 Change 2009 Change
- Income before Taxes $43.9 $29.7 48 % $41.9 5 %
- Depreciation and Amortization 14.1 10.9 30 14.2 -
- Interest 4.0 3.9 2 4.4 (11 )
- EBITDA $62.0 $44.5 40 $60.5 3
- Cash Flow from Operating Activities $84.8 $72.8 16 % $55.3 53 %
- Capital Expenditures (7.4 ) (5.9 ) 25 (6.1 ) 21
- Excess Tax Benefit from Stock-Based Compensation 0.3 0.6 (52 ) 0.6 (58 )
- Free Cash Flow $77.7 $67.5 15 $49.8 56
Forward-Looking Statements
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act of 1934, as amended. These statements may relate to, among other things, capital expenditures, cost reductions, cash flow, and operating improvements and are indicated by words or phrases such as "anticipate," "estimate," "plans," "expects," "projects," "should," "will," "management believes," "the company believes," "the company intends," and similar words or phrases. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this news release. The risks and uncertainties include, but are not limited to, the following: economic and political consequences resulting from terrorist attacks and wars; levels of industrial activity and economic conditions in the U.S. and other countries around the world; pricing pressures and other competitive factors, and levels of capital spending in certain industries -- all of which could have a material impact on order rates and IDEX's results, particularly in light of the low levels of order backlogs it typically maintains; its ability to make acquisitions and to integrate and operate acquired businesses on a profitable basis; the relationship of the U.S. dollar to other currencies and its impact on pricing and cost competitiveness; political and economic conditions in foreign countries in which the company operates; interest rates; capacity utilization and the effect this has on costs; labor markets; market conditions and material costs; and developments with respect to contingencies, such as litigation and environmental matters. The forward-looking statements included here are only made as of the date of this news release, and management undertakes no obligation to publicly update them to reflect subsequent events or circumstances. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented here.
About IDEX
IDEX Corporation is an applied solutions company specializing in fluid and metering technologies, health and science technologies, dispensing equipment, and fire, safety and other diversified products built to its customers' exacting specifications. Its products are sold in niche markets to a wide range of industries throughout the world. IDEX shares are traded on the New York Stock Exchange and Chicago Stock Exchange under the symbol "IEX".
For further information on IDEX Corporation and its business units, visit the company's Web site at www.idexcorp.com.
(Tables follow)
IDEX CORPORATION
IDEX CORPORATION
Condensed Statements of Consolidated Operations
(in thousands except per share amounts)
Three Months Ended Nine Months Ended
September 30, September 30,
2009 2008 (a) 2009 2008 (a)
Net sales $ 323,249 $ 365,193 $ 986,317 $1,134,165
Cost of sales 194,191 217,409 602,964 672,391
Gross profit 129,058 147,784 383,353 461,774
Selling, general and administrative expenses 79,789 81,614 242,687 258,082
Goodwill impairment - 30,090 - 30,090
Restructuring expenses 2,752 5,276 8,253 5,276
Operating income 46,517 30,804 132,413 168,326
Other income - net 1,382 2,723 806 3,885
Interest expense 3,951 3,861 13,212 13,619
Income before income taxes 43,948 29,666 120,007 158,592
Provision for income taxes 14,171 9,783 39,703 54,046
Net income $ 29,777 $ 19,883 $ 80,304 $ 104,546
Earnings per Common Share:
Basic earnings per common share (b) $ 0.37 $ 0.24 $ 1.00 $ 1.27
Diluted earnings per common share (b) $ 0.37 $ 0.24 $ 0.99 $ 1.26
Share Data:
Basic weighted average common shares outstanding 79,740 81,572 79,642 81,320
Diluted weighted average common shares outstanding 80,879 82,957 80,535 82,663
Condensed Consolidated Balance Sheets
(in thousands)
September 30, December 31,
2009 2008 (a)
Assets
Current assets
Cash and cash equivalents $ 74,429 $ 61,353
Receivables - net 189,417 205,269
Inventories 162,384 181,200
Other current assets 32,363 32,866
Total current assets 458,593 480,688
Property, plant and equipment - net 181,006 186,283
Goodwill and intangible assets 1,474,552 1,470,289
Other noncurrent assets 10,056 14,540
Total assets $ 2,124,207 $2,151,800
Liabilities and shareholders' equity
Current liabilities
Trade accounts payable $ 76,321 $ 87,304
Accrued expenses 114,676 117,186
Short-term borrowings 6,307 5,856
Dividends payable 9,554 9,523
Total current liabilities 206,858 219,869
Long-term borrowings 440,832 548,144
Other noncurrent liabilities 240,141 239,004
Total liabilities 887,831 1,007,017
Shareholders' equity 1,236,376 1,144,783
Total liabilities and shareholders' equity $ 2,124,207 $2,151,800
IDEX CORPORATION
IDEX CORPORATION
Company and Business Group Financial Information
(dollars in thousands)
Three Months Ended Nine Months Ended
September 30, September 30,
2009 (c) 2008 (a) 2009 (c) 2008 (a)
Fluid & Metering Technologies
Net sales $ 156,939 $ 170,258 $ 470,957 $ 518,546
Operating income (d) 26,412 35,164 73,773 99,735
Operating margin 16.8 % 20.7 % 15.7 % 19.2 %
Depreciation and amortization $ 8,061 $ 5,842 $ 24,396 $ 18,605
Capital expenditures 3,810 2,519 9,682 7,695
Health & Science Technologies
Net sales $ 76,138 $ 82,889 $ 224,142 $ 253,778
Operating income (d) 15,312 17,623 37,422 48,507
Operating margin 20.1 % 21.3 % 16.7 % 19.1 %
Depreciation and amortization $ 3,866 $ 2,573 $ 10,579 $ 8,411
Capital expenditures 1,879 1,294 3,793 3,894
Dispensing Equipment
Net sales $ 25,580 $ 31,543 $ 104,111 $ 138,152
Operating income (d) 319 931 14,319 26,431
Operating margin 1.2 % 3.0 % 13.8 % 19.1 %
Depreciation and amortization $ 670 $ 946 $ 2,340 $ 3,215
Capital expenditures 292 652 850 2,236
Fire & Safety/Diversified Products
Net sales $ 65,524 $ 81,189 $ 192,633 $ 227,099
Operating income (d) 15,956 20,514 43,265 57,072
Operating margin 24.4 % 25.3 % 22.5 % 25.1 %
Depreciation and amortization $ 1,287 $ 1,206 $ 3,815 $ 3,950
Capital expenditures 853 789 2,569 3,929
Company
Net sales $ 323,249 $ 365,193 $ 986,317 $ 1,134,165
Operating income 49,269 66,170 140,666 203,692
Operating margin 15.2 % 18.1 % 14.3 % 18.0 %
Depreciation and amortization (e) $ 14,135 $ 10,879 $ 41,893 $ 35,092
Capital expenditures 7,081 5,851 18,303 19,164
(a) Certain prior year amounts have been restated to reflect the LIFO
to FIFO inventory costing change.
(b) Adjusted to reflect the accounting guidance provided in FSP EITF
03-6-1, "Determining Whether Instruments Granted in Share-Based
Payment Transactions are Participating Securities."
(c) Three and nine month data includes acquisition of IETG (October
2008), iPEK (October 2008) and Richter (October 2008) in the Fluid &
Metering Technologies Group and Semrock (October 2008) in the Health
& Science Technologies Group from the date of acquisition.
(d) Group operating income excludes unallocated corporate operating
expenses, restructuring-related charges and the 2008 goodwill
impairment charge within the Dispensing Equipment group.
(e) Excludes amortization of debt issuance expenses.
SOURCE: IDEX Corporation
IDEX Corporation Investor Contact: Heath Mitts Vice President -- Corporate Finance (847) 498-7070
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.